These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 22490788)

  • 1. [Pharmacotherapy in diabetics with arterial occlusion of lower extremity].
    Wang AH; Xu ZR
    Zhonghua Yi Xue Za Zhi; 2012 Jan; 92(4):219-20. PubMed ID: 22490788
    [No Abstract]   [Full Text] [Related]  

  • 2. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia.
    Van Belle E; Nikol S; Norgren L; Baumgartner I; Driver V; Hiatt WR; Belch J
    Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):365-73. PubMed ID: 21696982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of occlusive peripheral arterial disease of the lower limbs].
    Ponsonnaille J
    Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1177-8. PubMed ID: 16435594
    [No Abstract]   [Full Text] [Related]  

  • 4. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia.
    Wang J; Zhu YQ; Li MH; Zhao JG; Tan HQ; Wang JB; Liu F; Cheng YS
    J Vasc Interv Radiol; 2011 Jul; 22(7):987-94. PubMed ID: 21570870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fully implantable catheter systems for arterial extremity infusion].
    Krawzak HW; Strosche H
    Chirurg; 1989 Jul; 60(7):475-8. PubMed ID: 2791734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison between L-propionyl carnitine and physical-rehabilitative exercise in diabetics with obliterative arteriopathy of the legs (Fontaine's stage IIa)].
    Costanza G; Di Salvo A; Barone G; Verruso G; Zamueli M; Marchese G
    Minerva Cardioangiol; 1999 Dec; 47(12):649-50. PubMed ID: 10670244
    [No Abstract]   [Full Text] [Related]  

  • 7. [In diabetes and peripheral arterial occlusive disease: long-term treatment with clopidogrel].
    Baumgartner I
    Praxis (Bern 1994); 2005 May; 94(19):770-1. PubMed ID: 15940908
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical application of MR and CT angiography in diabetic patients with peripheral arterial occlusive disease].
    Zhang L
    Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(3):161-2. PubMed ID: 23570585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C; Hofmann U; König P; Nitsche GB
    Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
    [No Abstract]   [Full Text] [Related]  

  • 10. [Management of obliterating arteriopathy of the lower limbs in the diabetic patient].
    Priollet P
    Rev Prat; 2005 Jun; 55(11):1193-4. PubMed ID: 16211771
    [No Abstract]   [Full Text] [Related]  

  • 11. Which diabetics are at risk for lower-extremity problems and what preventive measures can be taken?
    Nair DG; Samson R
    Semin Vasc Surg; 2008 Sep; 21(3):154-9. PubMed ID: 18774451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefits of iloprost, a stable prostacyclin (PGI2) analog, in severe peripheral arterial disease (PAD).
    Oberender H; Krais T; Schäfer M; Belcher G
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():311-6. PubMed ID: 2473610
    [No Abstract]   [Full Text] [Related]  

  • 13. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of prostaglandin El on hemodynamics and metabolism of the extremities in healthy humans and patients with stage III and IV arterial occlusive disease].
    Rexroth W; Amendt K; Römmele U; Stein U; Wagner E; Hild R
    Vasa; 1985; 14(3):220-4. PubMed ID: 4050061
    [No Abstract]   [Full Text] [Related]  

  • 15. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
    Hinderer S; Brachmann R; Nedder KH; Bucher J; Beischer W
    Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia.
    Orrico C; Pasquinelli G; Foroni L; Muscarà D; Tazzari PL; Ricci F; Buzzi M; Baldi E; Muccini N; Gargiulo M; Stella A
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):365-74. PubMed ID: 20570185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does prostacyclin analogue Iloprost change blood rheology? Results from a double blind trial with intravenous application in diabetics.
    Ernst E; Marshall M; Matrai A
    Vasa; 1988; 17(2):89-91. PubMed ID: 2457284
    [No Abstract]   [Full Text] [Related]  

  • 18. [B mode blood flow imaging in the diagnosis of diseases of lower extremities in diabetic patients].
    Jin R; Ji FY; Wang Z; Li L; Huang XY; Jiao T
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):716. PubMed ID: 18093425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methods of treatment in patients with lower extremity arterial occlusive disease in presence of distal arterial lesion(Part 1)].
    Gavrilenko AV; Egorov AA; Molokopoĭ SN; Mamukhov AS
    Angiol Sosud Khir; 2011; 17(3):121-5. PubMed ID: 22229169
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostacyclin in peripheral arterial occlusive disease (PAOD): clinical and hemodynamic findings in patients with PAOD stage III and IV.
    Valentin A; Karnik R; Sehnal E; Slany J
    Prog Clin Biol Res; 1987; 242():457-62. PubMed ID: 3313420
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.